Glucagon clinical trials: 79 trials
Page 1 of 2
Read 79 Glucagon clinical trials with posted results or linked papers with results in PepBank.
- A Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Type 1 Diabetes Subjects
NCT03378635 · Phase 3 · Completed
Posted results
- G-Pen Compared to Glucagen Hypokit for Severe Hypoglycemia Rescue in Adults With Type 1 Diabetes
NCT03738865 · Phase 3 · Completed
Posted results
- Clinical Usability of Intranasal Glucagon in Treatment of Hypoglycemia
NCT02171130 · Phase 3 · Completed
Posted results
- EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)
NCT02635386 · Phase 3 · Completed
Posted results
- A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes Mellitus
NCT03216226 · Phase 3 · Completed
Posted results
- FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)
NCT01524705 · Phase 4 · Completed
Posted results
- Glucagon Use in Colonoscopies
NCT02078726 · Phase 4 · Completed
Posted results
- G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes
NCT03439072 · Phase 3 · Completed
Posted results
- Safety and Efficacy of G-Pen Compared to Lilly Glucagon for Hypoglycemia Rescue in Adult Type 1 Diabetics
NCT02656069 · Phase 3 · Completed
Posted results
- Efficacy and Safety of Nasal Glucagon for Treatment of Hypoglycemia in Adults
NCT01994746 · Phase 3 · Completed
Posted results
- A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus
NCT03421379 · Phase 3 · Completed
Posted results
- Evaluate the Immunogenicity of a Novel Glucagon Formulation
NCT01959334 · Phase 3 · Completed
Posted results
- Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 Diabetes
NCT01997411 · Phase 2/3 · Completed
Posted results
- Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in T1DM Children
NCT03667053 · Phase 3 · Completed
Posted results
- Glucose Response of G-Pen (Glucagon Injection) in Pediatric T1D Patients
NCT03091673 · Phase 3 · Completed
Posted results
- Clinical Usability of Nasal Glucagon in Treatment of Hypoglycemia in Children and Adolescents
NCT02402933 · Phase 3 · Completed
Posted results
- Effect of Ethanol Intoxication on the Anti-Hypoglycemic Action of Glucagon
NCT02516150 · Phase 4 · Completed
Posted results
- Equivalence of A Stable Liquid Glucagon Formulation With Freshly Reconstituted Lyophilized Glucagon
NCT02018627 · Phase 2/3 · Completed
Posted results
- The Effect of Glucagon-like-peptide 1 (GLP-1) Receptor Agonism on Diabetic Kidney Disease
NCT01847313 · Phase 3 · Completed
Posted results
- Glucagon Modulation of Ghrelin Secretion
NCT00929812 · Phase 3 · Status unknown
Linked paper with results
- The Role of Amylin and Glucagon in T1DM
NCT00206258 · Phase 3 · Completed
Linked paper with results
- Stimulation Test With Intranasal Glucagon for Corticotroph, Somatotroph and Antidiuretic Axes
NCT05206149 · Phase 4 · Completed
Linked paper with results
- Effects of ROSE-010 on GI Transit in Constipation Predominant Irritable Bowel Syndrome (C-IBS) Patients
NCT01056107 · Phase 1/2 · Completed
Posted results
- The Effect of Surgically Induced Weight Loss on Endocrine Function, Cardiovascular Function and Body Composition
NCT00686972 · Phase 2 · Terminated
Posted results
- Glucagon Infusion in T1D Patients With Recurrent Severe Hypoglycemia: Effects on Counter-Regulatory Responses
NCT03490942 · Phase 2 · Terminated
Posted results
- Glucagon Ready-to-Use (RTU) for Prevention of Exercise-Induced Hypoglycemia During Aerobic Exercise in Adults With T1D
NCT03841526 · Phase 2 · Completed
Posted results
- Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of G-Pen(TM) (Glucagon Injection) to Treat Severe Hypoglycemia
NCT01972152 · Phase 2 · Completed
Posted results
- Mini-Dose Glucagon to Treat Non-Severe Hypoglycemia
NCT02411578 · Phase 2 · Completed
Posted results
- The Effects of Glucagon on Hepatic Metabolism
NCT05500586 · Phase 1/2 · Completed
Posted results
- Effect of GLP-1 on Insulin Biosynthesis and Turnover Rates
NCT00609154 · Phase 1/2 · Terminated
Posted results
- PK/PD Study With G-Pump (Glucagon Infusion) in T1DM Patients
NCT02081001 · Phase 2 · Completed
Posted results
- The Efficacy of Glucagon Like Peptide (GLP) - 1(7-36) Amide for Glycemic Control in Critically Ill Patients
NCT00798590 · Phase 2 · Terminated
Posted results
- Closed-Loop Glucagon Pump for Treatment of Post-Bariatric Hypoglycemia
NCT03255629 · Phase 1/2 · Completed
Posted results
- Safety and Efficacy of a Novel Glucagon Formulation in Type 1 Diabetic Patients Following Insulin-induced Hypoglycemia
NCT01556594 · Phase 2 · Completed
Posted results
- The Use of Mini-dose Glucagon to Prevent Exercise-induced Hypoglycemia in Type 1 Diabetes
NCT02660242 · Phase 2 · Completed
Posted results
- Sensor-Augmented Insulin Delivery: Insulin Plus Glucagon Versus Insulin Alone
NCT00797823 · Phase 2 · Completed
Posted results
- Feasibility Trial Testing the Bionic Pancreas With ZP4207
NCT02971228 · Phase 2 · Completed
Posted results
- Safety and Efficacy Study of Mini-Dose Glucagon (G-Pen Mini) in Patients With Type 1 Diabetes
NCT02081014 · Phase 2 · Completed
Posted results
- Delivery of G-Pump™ (Glucagon Infusion) From an OmniPod® to Prevent Hypoglycemia in Post-Bariatric Surgery Patients
NCT02733588 · Phase 2 · Completed
Posted results
- G-Pen™ for Hypoglycemia Rescue in T1D Patients
NCT02423980 · Phase 2 · Completed
Posted results
- CSI-Glucagon for Prevention of Hypoglycemia in Children With Congenital Hyperinsulinism
NCT02937558 · Phase 2 · Completed
Posted results
- Single Doses of ZP4207 Adm. sc to Hypoglycemic TD1 pt. to Describe the PK and PD of ZP4207 as Comp. to Marketed Glucagon
NCT02660008 · Phase 2 · Completed
Linked paper with results
- Glucagon Enhanced Insulin Absorption in Diabetes Mellitus Type 1
NCT05960565 · Phase 2 · Terminated
Linked paper with results
- A Study Comparing User Experience of Different Delivery Devices for Glucagon
NCT03765502 · Phase 1 · Completed
Posted results
- A Study of Nasal Glucagon in Participants With Type 1 Diabetes Mellitus
NCT03339453 · Phase 1 · Completed
Posted results
- A Study of Nasal Glucagon in Participants With a Common Cold
NCT02778100 · Phase 1 · Completed
Posted results
- A Study of Single or Repeated Doses of Glucagon in Participants With Diabetes
NCT02806973 · Phase 1 · Completed
Posted results
- Effect of LY2189265 on Insulin Secretion in Response to Intravenous Glucose
NCT01300260 · Phase 1 · Completed
Posted results
- Three Way Crossover Closed Loop Study With Xeris Glucagon
NCT03424044 · Phase 1 · Completed
Posted results
- Study of LY2409021 in Participants With Type 1 Diabetes
NCT01640834 · Phase 1 · Completed
Posted results